Literature DB >> 10950105

Early detection cancer research network.

S Srivastava, B S Kramer.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10950105     DOI： 10.1038/labinvest.3780122

Source DB:  PubMed          Journal:  Lab Invest        ISSN： 0023-6837            Impact factor:   5.662


× No keyword cloud information.
  10 in total

Review 1.  NIST physical standards for DNA-based medical testing.

Authors:  Peter E Barker; Michael S Watson; John R Ticehurst; Jennifer C Colbert; Catherine D O'Connell
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

2.  Projecting Benefits and Harms of Novel Cancer Screening Biomarkers: A Study of PCA3 and Prostate Cancer.

Authors:  Jeanette K Birnbaum; Ziding Feng; Roman Gulati; Jing Fan; Yair Lotan; John T Wei; Ruth Etzioni
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-01-22       Impact factor: 4.254

3.  Methods for Assessing Improvement in Specificity when a Biomarker is Combined with a Standard Screening Test.

Authors:  Pamela A Shaw; Margaret S Pepe; Todd A Alonzo; Ruth Etzioni
Journal:  Stat Biopharm Res       Date:  2009-02-01       Impact factor: 1.452

4.  A mouse model repository for cancer biomarker discovery.

Authors:  Karen S Kelly-Spratt; A Erik Kasarda; Mark Igra; Christopher J Kemp
Journal:  J Proteome Res       Date:  2008-07-15       Impact factor: 4.466

5.  Analytical validation of telomerase activity for cancer early detection: TRAP/PCR-CE and hTERT mRNA quantification assay for high-throughput screening of tumor cells.

Authors:  John P Jakupciak; Wendy Wang; Peter E Barker; Sudhir Srivastava; Donald H Atha
Journal:  J Mol Diagn       Date:  2004-08       Impact factor: 5.568

6.  Application of a global proteomic approach to archival precursor lesions: deleted in malignant brain tumors 1 and tissue transglutaminase 2 are upregulated in pancreatic cancer precursors.

Authors:  Wang Cheung; Marlene M Darfler; Hector Alvarez; Brian L Hood; Thomas P Conrads; Nils Habbe; David B Krizman; Jan Mollenhauer; Georg Feldmann; Anirban Maitra
Journal:  Pancreatology       Date:  2008-10-13       Impact factor: 3.996

Review 7.  Detection of cancer-specific epigenomic changes in biofluids: powerful tools in biomarker discovery and application.

Authors:  André Nogueira da Costa; Zdenko Herceg
Journal:  Mol Oncol       Date:  2012-08-16       Impact factor: 6.603

8.  An Automated Peak Identification/Calibration Procedure for High-Dimensional Protein Measures From Mass Spectrometers.

Authors:  Yutaka Yasui; Dale McLerran; Bao-Ling Adam; Marcy Winget; Mark Thornquist; Ziding Feng
Journal:  J Biomed Biotechnol       Date:  2003

9.  Summarizing performance for genome scale measurement of miRNA: reference samples and metrics.

Authors:  P Scott Pine; Steven P Lund; Jerod R Parsons; Lindsay K Vang; Ashish A Mahabal; Luca Cinquini; Sean C Kelly; Heather Kincaid; Daniel J Crichton; Avrum Spira; Gang Liu; Adam C Gower; Harvey I Pass; Chandra Goparaju; Steven M Dubinett; Kostyantyn Krysan; Sanford A Stass; Debra Kukuruga; Kendall Van Keuren-Jensen; Amanda Courtright-Lim; Karol L Thompson; Barry A Rosenzweig; Lynn Sorbara; Sudhir Srivastava; Marc L Salit
Journal:  BMC Genomics       Date:  2018-03-06       Impact factor: 3.969

10.  Cell-based reference samples designed with specific differences in microRNA biomarkers.

Authors:  P Scott Pine; Steven P Lund; Sanford A Stass; Debra Kukuruga; Feng Jiang; Lynn Sorbara; Sudhir Srivastava; Marc Salit
Journal:  BMC Biotechnol       Date:  2018-03-20       Impact factor: 2.563
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.